Resmed shares have taken a hit despite again reporting record revenue in the past financial year. (Bianca De Marchi/AAP PHOTOS)Resmed shares have taken a hit despite again reporting record revenue in the past financial year. (Bianca De Marchi/AAP PHOTOS) Credit: AAPAn ASX-listed Australian-American CPAP machine manufacturer has reported record revenue but its shares have dropped after global inflation took a toll on its profit margin. Resmed brought in a record $US1.5 billion ($2.1 billion) in revenue for the fourth quarter, bringing its total revenue for 2025/26 to $US5.7 billion ($8.1 billion), up 10 per cent from a year ago. RBC Capital Markets analyst Craig Wong-Pan said Resmed's revenue was in-line with consensus expectations, with a slight miss in the Americas and software-as-a-service offset with a beat in rest of world.